Understanding the Tip:
Why retaining empty containers helps resolve stability issues:
Packaging materials play a critical role in the stability of pharmaceutical products. If unexpected results arise—such as impurity spikes, potency loss, or moisture ingress—having retained reference containers from the same packaging lot can aid in identifying whether the issue is related to the packaging material or sealing integrity. These empty containers act as control samples for comparison in root cause investigations, reducing guesswork and improving resolution timelines.
Risks of not retaining packaging components:
Without retained reference containers:
- Root cause investigations may rely on indirect assumptions
- Issues such as poor sealing, delamination, or closure failures may go unverified
- Repeat incidents may occur if packaging flaws aren’t identified early
- Regulatory reviewers may question the completeness of your packaging evaluation
Maintaining a stock of representative empty containers ensures readiness for timely and evidence-based problem-solving.
Regulatory and Technical Context:
ICH and WHO perspectives on container-closure relevance:
ICH Q1A(R2) emphasizes the need to assess all aspects of container-closure systems in stability programs. WHO TRS 1010 reiterates the importance of demonstrating that packaging materials do not negatively impact product quality over time. CTD Modules 3.2.P.2, 3.2.P.7, and 3.2.P.8.3 all reference packaging integrity and compatibility. Regulatory bodies expect well-documented systems to track and investigate packaging-related stability failures.
Audit triggers
Auditors may ask:
- If container lots are traceable to specific stability studies
- What material characterization was performed on retained samples
- How packaging-related deviations were investigated using retained samples
Lack of physical references can limit the effectiveness of CAPA and weaken regulatory confidence in packaging controls.
Best Practices and Implementation:
Define retention requirements in stability SOPs:
Establish procedures to:
- Retain a set number of empty containers (e.g., 3–5 units) per packaging lot
- Include closures, labels, induction seals, and blister films as applicable
- Label and store these samples under controlled conditions (e.g., ambient, secure)
Ensure QA oversight and documentation within the stability program master file or packaging control records.
Use retained containers in failure investigations:
Apply retained samples to:
- Compare sealing profiles or torque characteristics
- Assess material degradation under stress conditions
- Perform extractable or FTIR analysis if contamination is suspected
Document findings and compare against affected batch packaging to identify discrepancies or trends.
Link retained packaging to regulatory documentation:
Reference retained containers in:
- Deviation and CAPA reports for packaging issues
- APQR or product quality review summaries
- Packaging development and compatibility studies (CTD 3.2.P.7)
Store long-term alongside stability study documentation to support regulatory audits and lifecycle reviews.
Retaining empty container samples is a simple yet powerful strategy to support stability-related investigations. It enhances troubleshooting speed, reinforces your packaging control system, and provides a proactive foundation for ensuring long-term product integrity.